328 related articles for article (PubMed ID: 27587537)
21. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
23. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.
Vandael DH; Ottaviani MM; Legros C; Lefort C; Guérineau NC; Allio A; Carabelli V; Carbone E
J Physiol; 2015 Feb; 593(4):905-27. PubMed ID: 25620605
[TBL] [Abstract][Full Text] [Related]
24. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
25. Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels.
Zhang H; Reichert E; Cohen AE
Elife; 2016 May; 5():. PubMed ID: 27215841
[TBL] [Abstract][Full Text] [Related]
26. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
Payandeh J; Hackos DH
Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
[TBL] [Abstract][Full Text] [Related]
27. Fast-onset lidocaine block of rat NaV1.4 channels suggests involvement of a second high-affinity open state.
Gingrich KJ; Wagner LE
Biochim Biophys Acta; 2016 Jun; 1858(6):1175-88. PubMed ID: 26922882
[TBL] [Abstract][Full Text] [Related]
28. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels.
Jones HM; Butt RP; Webster RW; Gurrell I; Dzygiel P; Flanagan N; Fraier D; Hay T; Iavarone LE; Luckwell J; Pearce H; Phipps A; Segelbacher J; Speed B; Beaumont K
Clin Pharmacokinet; 2016 Jul; 55(7):875-887. PubMed ID: 26895021
[TBL] [Abstract][Full Text] [Related]
29. Human Nav1.6 Channels Generate Larger Resurgent Currents than Human Nav1.1 Channels, but the Navβ4 Peptide Does Not Protect Either Isoform from Use-Dependent Reduction.
Patel RR; Barbosa C; Xiao Y; Cummins TR
PLoS One; 2015; 10(7):e0133485. PubMed ID: 26182346
[TBL] [Abstract][Full Text] [Related]
30. Modulation of human Nav1.7 channel gating by synthetic α-scorpion toxin OD1 and its analogs.
Motin L; Durek T; Adams DJ
Channels (Austin); 2016; 10(2):139-47. PubMed ID: 26646206
[TBL] [Abstract][Full Text] [Related]
31. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Sun S; Cohen CJ; Dehnhardt CM
Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
[TBL] [Abstract][Full Text] [Related]
32. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.
Ahuja S; Mukund S; Deng L; Khakh K; Chang E; Ho H; Shriver S; Young C; Lin S; Johnson JP; Wu P; Li J; Coons M; Tam C; Brillantes B; Sampang H; Mortara K; Bowman KK; Clark KR; Estevez A; Xie Z; Verschoof H; Grimwood M; Dehnhardt C; Andrez JC; Focken T; Sutherlin DP; Safina BS; Starovasnik MA; Ortwine DF; Franke Y; Cohen CJ; Hackos DH; Koth CM; Payandeh J
Science; 2015 Dec; 350(6267):aac5464. PubMed ID: 26680203
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
35. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
36. Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
Xu H; Li T; Rohou A; Arthur CP; Tzakoniati F; Wong E; Estevez A; Kugel C; Franke Y; Chen J; Ciferri C; Hackos DH; Koth CM; Payandeh J
Cell; 2019 Feb; 176(4):702-715.e14. PubMed ID: 30661758
[TBL] [Abstract][Full Text] [Related]
37. Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.
Cardoso FC; Dekan Z; Smith JJ; Deuis JR; Vetter I; Herzig V; Alewood PF; King GF; Lewis RJ
Br J Pharmacol; 2017 Aug; 174(15):2528-2544. PubMed ID: 28542706
[TBL] [Abstract][Full Text] [Related]
38. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.
Herzog RI; Cummins TR; Ghassemi F; Dib-Hajj SD; Waxman SG
J Physiol; 2003 Sep; 551(Pt 3):741-50. PubMed ID: 12843211
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.
Niu HL; Liu YN; Xue DQ; Dong LY; Liu HJ; Wang J; Zheng YL; Zou AR; Shao LM; Wang K
Acta Pharmacol Sin; 2021 Aug; 42(8):1235-1247. PubMed ID: 34103689
[TBL] [Abstract][Full Text] [Related]
40. Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic Effects against Pain.
Zeng X; Li P; Chen B; Huang J; Lai R; Liu J; Rong M
Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29393892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
